Neoadjuvant chemo-immunotherapy for lung cancer: how much is too much?

Nathaniel Deboever, Jianjun Zhang

Research output: Contribution to journalEditorialpeer-review

1 Scopus citations
Original languageEnglish (US)
Pages (from-to)2360-2363
Number of pages4
JournalTranslational Lung Cancer Research
Volume11
Issue number12
DOIs
StatePublished - Dec 2022
Externally publishedYes

Keywords

  • Neoadjuvant immunotherapy
  • non-small cell lung cancer (NSCLC)
  • protocol length

ASJC Scopus subject areas

  • Oncology

Cite this